Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Nat Commun
2022 Feb 17;131:923. doi: 10.1038/s41467-022-28559-3.
Show Gene links
Show Anatomy links
Development and characterization of functional antibodies targeting NMDA receptors.
Tajima N
,
Simorowski N
,
Yovanno RA
,
Regan MC
,
Michalski K
,
Gómez R
,
Lau AY
,
Furukawa H
.
???displayArticle.abstract???
N-methyl-D-aspartate receptors (NMDARs) are critically involved in basic brain functions and neurodegeneration as well as tumor invasiveness. Targeting specific subtypes of NMDARs with distinct activities has been considered an effective therapeutic strategy for neurological disorders and diseases. However, complete elimination of off-target effects of small chemical compounds has been challenging and thus, there is a need to explore alternative strategies for targeting NMDAR subtypes. Here we report identification of a functional antibody that specifically targets the GluN1-GluN2B NMDAR subtype and allosterically down-regulates ion channel activity as assessed by electrophysiology. Through biochemical analysis, x-ray crystallography, single-particle electron cryomicroscopy, and molecular dynamics simulations, we show that this inhibitory antibody recognizes the amino terminal domain of the GluN2B subunit and increases the population of the non-active conformational state. The current study demonstrates that antibodies may serve as specific reagents to regulate NMDAR functions for basic research and therapeutic objectives.
Adams,
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
2010, Pubmed
Adams,
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
2010,
Pubmed
Botello-Smith,
Robust Determination of Protein Allosteric Signaling Pathways.
2019,
Pubmed
Chan,
Lupus autoantibodies act as positive allosteric modulators at GluN2A-containing NMDA receptors and impair spatial memory.
2020,
Pubmed
Chou,
Structural Basis of Functional Transitions in Mammalian NMDA Receptors.
2020,
Pubmed
Demattos,
A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice.
2012,
Pubmed
Fares,
Immune checkpoint inhibitors: Advances and impact in neuro-oncology.
2019,
Pubmed
Farina,
Separation of domain contacts is required for heterotetrameric assembly of functional NMDA receptors.
2011,
Pubmed
Furukawa,
Subunit arrangement and function in NMDA receptors.
2005,
Pubmed
Furukawa,
Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.
2003,
Pubmed
Furukawa,
Effective production of oligomeric membrane proteins by EarlyBac-insect cell system.
2021,
Pubmed
Gao,
Two-state selection of conformation-specific antibodies.
2009,
Pubmed
Gleichman,
Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain.
2012,
Pubmed
Grant,
cisTEM, user-friendly software for single-particle image processing.
2018,
Pubmed
Grigorieff,
Frealign: An Exploratory Tool for Single-Particle Cryo-EM.
2016,
Pubmed
Hackos,
Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
2016,
Pubmed
Hansen,
Structure, function, and allosteric modulation of NMDA receptors.
2018,
Pubmed
Hansen,
Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors.
2013,
Pubmed
,
Xenbase
Hansen,
Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
2014,
Pubmed
,
Xenbase
Holliger,
"Diabodies": small bivalent and bispecific antibody fragments.
1993,
Pubmed
Hughes,
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.
2010,
Pubmed
Humphrey,
VMD: visual molecular dynamics.
1996,
Pubmed
Ikonomidou,
Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?
2002,
Pubmed
Inanobe,
Mechanism of partial agonist action at the NR1 subunit of NMDA receptors.
2005,
Pubmed
,
Xenbase
Jalali-Yazdi,
Mechanisms for Zinc and Proton Inhibition of the GluN1/GluN2A NMDA Receptor.
2018,
Pubmed
Jespersen,
Structural insights into competitive antagonism in NMDA receptors.
2014,
Pubmed
,
Xenbase
Jo,
CHARMM-GUI: a web-based graphical user interface for CHARMM.
2008,
Pubmed
Karakas,
Emerging structural insights into the function of ionotropic glutamate receptors.
2015,
Pubmed
Karakas,
Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
2011,
Pubmed
,
Xenbase
Karakas,
Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit.
2009,
Pubmed
,
Xenbase
Karakas,
Crystal structure of a heterotetrameric NMDA receptor ion channel.
2014,
Pubmed
Lange,
Generalized correlation for biomolecular dynamics.
2006,
Pubmed
Lee,
NMDA receptor structures reveal subunit arrangement and pore architecture.
2014,
Pubmed
,
Xenbase
Li,
GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth.
2018,
Pubmed
Li,
Hijacking the neuronal NMDAR signaling circuit to promote tumor growth and invasion.
2013,
Pubmed
Li,
A set of van der Waals and coulombic radii of protein atoms for molecular and solvent-accessible surface calculation, packing evaluation, and docking.
1998,
Pubmed
Lind,
Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits.
2017,
Pubmed
,
Xenbase
Lipton,
Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults.
2004,
Pubmed
Luan,
Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations.
2021,
Pubmed
Lü,
Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation.
2017,
Pubmed
,
Xenbase
McCoy,
Phaser crystallographic software.
2007,
Pubmed
McGibbon,
MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics Trajectories.
2015,
Pubmed
Melo,
Generalized correlation-based dynamical network analysis: a new high-performance approach for identifying allosteric communications in molecular dynamics trajectories.
2020,
Pubmed
Michaud-Agrawal,
MDAnalysis: a toolkit for the analysis of molecular dynamics simulations.
2011,
Pubmed
Monyer,
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.
1994,
Pubmed
Otwinowski,
Processing of X-ray diffraction data collected in oscillation mode.
1997,
Pubmed
Parsons,
Extrasynaptic NMDA receptor involvement in central nervous system disorders.
2014,
Pubmed
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Phillips,
Scalable molecular dynamics with NAMD.
2005,
Pubmed
Regan,
A structural biology perspective on NMDA receptor pharmacology and function.
2015,
Pubmed
Regan,
Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors.
2019,
Pubmed
,
Xenbase
Regan,
Structural Mechanism of Functional Modulation by Gene Splicing in NMDA Receptors.
2018,
Pubmed
,
Xenbase
Romero-Hernandez,
Novel Mode of Antagonist Binding in NMDA Receptors Revealed by the Crystal Structure of the GluN1-GluN2A Ligand-Binding Domain Complexed to NVP-AAM077.
2017,
Pubmed
,
Xenbase
Romero-Hernandez,
Molecular Basis for Subtype Specificity and High-Affinity Zinc Inhibition in the GluN1-GluN2A NMDA Receptor Amino-Terminal Domain.
2016,
Pubmed
,
Xenbase
Shrake,
Environment and exposure to solvent of protein atoms. Lysozyme and insulin.
1973,
Pubmed
Song,
Mechanism of NMDA receptor channel block by MK-801 and memantine.
2018,
Pubmed
,
Xenbase
Stroebel,
A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
2016,
Pubmed
,
Xenbase
Tajima,
Activation of NMDA receptors and the mechanism of inhibition by ifenprodil.
2016,
Pubmed
Tegunov,
Real-time cryo-electron microscopy data preprocessing with Warp.
2019,
Pubmed
Toleikis,
Cloning single-chain antibody fragments (scFv) from hybridoma cells.
2004,
Pubmed
Vance,
Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors.
2011,
Pubmed
Wang,
Dissecting diverse functions of NMDA receptors by structural biology.
2019,
Pubmed
Wang,
Structural basis of subtype-selective competitive antagonism for GluN2C/2D-containing NMDA receptors.
2020,
Pubmed
,
Xenbase
Wang,
Gating mechanism and a modulatory niche of human GluN1-GluN2A NMDA receptors.
2021,
Pubmed
Wang,
Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta.
2016,
Pubmed
Webb,
Comparative Protein Structure Modeling Using MODELLER.
2016,
Pubmed
Yao,
Molecular mechanism of ligand recognition by NR3 subtype glutamate receptors.
2008,
Pubmed
Zhang,
Structural Basis of the Proton Sensitivity of Human GluN1-GluN2A NMDA Receptors.
2018,
Pubmed
,
Xenbase
Zhu,
Mechanism of NMDA Receptor Inhibition and Activation.
2016,
Pubmed
,
Xenbase
